key: cord-0920567-v983h8ut
authors: Asthana, Abhishek; Gaughan, Christina; Dong, Beihua; Weiss, Susan R.; Silverman, Robert H.
title: Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity
date: 2021-08-10
journal: mBio
DOI: 10.1128/mbio.01781-21
sha: 0c5bb3313209f5e9e6a7576c5e4479fa750a69ee
doc_id: 920567
cord_uid: v983h8ut

The 2′,5′-oligoadenylate (2-5A)-dependent endoribonuclease, RNase L, is a principal mediator of the interferon (IFN) antiviral response. Therefore, the regulation of cellular levels of 2-5A is a key point of control in antiviral innate immunity. Cellular 2-5A levels are determined by IFN-inducible 2′,5′-oligoadenylate synthetases (OASs) and by enzymes that degrade 2-5A. Importantly, many coronaviruses (CoVs) and rotaviruses encode 2-5A-degrading enzymes, thereby antagonizing RNase L and its antiviral effects. A-kinase-anchoring protein 7 (AKAP7), a mammalian counterpart, could possibly limit tissue damage from excessive or prolonged RNase L activation during viral infections or from self-double-stranded RNAs that activate OAS. We show that these enzymes, members of the two-histidine phosphoesterase (2H-PE) superfamily, constitute a subfamily referred here as 2′,5′-PEs. 2′,5′-PEs from the mouse CoV mouse hepatitis virus (MHV) (NS2), Middle East respiratory syndrome coronavirus (MERS-CoV) (NS4b), group A rotavirus (VP3), and mouse (AKAP7) were investigated for their evolutionary relationships and activities. While there was no activity against 3′,5′-oligoribonucleotides, they all cleaved 2′,5′-oligoadenylates efficiently but with variable activity against other 2′,5′-oligonucleotides. The 2′,5′-PEs are shown to be metal ion-independent enzymes that cleave trimer 2-5A (2′,5′-p(3)A(3)) producing mono- or diadenylates with 2′,3′-cyclic phosphate termini. Our results suggest that the elimination of 2-5A might be the sole function of viral 2′,5′-PEs, thereby promoting viral escape from innate immunity by preventing or limiting the activation of RNase L.

evade the antiviral effector RNase L, we further investigated MHV NS2, MERS-CoV NS4b (MERS-NS4b), the rotavirus group A (RVA) VP3 C-terminal domain (VP3-CTD), and mouse AKAP7 (muAKAP7) (Fig. 1B) . A comparison of the domain organizations of these 29,59-PEs shows a related, catalytic domain. Some of these enzymes have additional domains related to intracellular localization, nucleic acid metabolism, or protein binding functions indicative of their cellular compartment-specific or accessory functions (Fig. 1B) . For instance, MERS-CoV NS4b and muAKAP7 contain N-terminal nuclear (27) . Guanylyltransferase (Gtase) and methyltransferase (Mtase) domains are also shown (25, 29) . The mitochondrial-matrix-targeting peptide (MTP) and the catalytic EEP domain of PDE12 are shown (55) . Domains shown are not drawn to scale. localization signal (NLS) domains (24, 27, 28) . VP3 is a multifunctional enzyme that contains N-terminal guanylyltransferase (Gtase) and methyltransferase (Mtase) domains involved in the capping of the 59 termini of viral mRNAs (25, 29) . muAKAP7 also has a carboxy-terminal binding domain for regulatory subunit II (RII) of cyclic AMP (cAMP)dependent protein kinase A (PKA-RII-a-BD) (27) . In addition, MHV NS2 protein has a Cterminal extension of unknown identity or function (Fig. 1B) .

To determine the phylogenetic relationships between the different 29,59-PEs, we constructed a tree for amino acid sequences containing the catalytic domains from coronavirus, rotavirus, and mammalian 29,59-PEs ( Fig. 2A) . 29,59-PEs were distributed into two distinct branches on the phylogenetic tree. The VP3 group of proteins clustered into one branch, while the other three groups containing NS2, NS4b, and AKAP7 formed a separate branch ( Fig. 2A) . Within the VP3 group, RVA and rotavirus group B (RVB) resolved on distinct subbranches. Previously, full-length VP3s from RVA and RVB were also shown as separate distinct branches analogous to two separate clades (clade A and clade B) (30, 31) . Interestingly, the NS2 proteins were most closely related to the mammalian AKAP7 catalytic domains and then to the bat coronaviruses (HKU5 and SC2013) and MERS-CoV. The rotavirus VP3 proteins were most distally related to the other 29,59-PEs.

Based on the phylogenetic relationship and functional relatedness, we further analyzed the sequence conservation by amino acid alignment. 2H-PE superfamily members are characterized by the presence of two H-f -S/T-f motifs, separated by an average of 80 amino acids (aa) (where f represents a hydrophobic amino acid) (19) . The alignment shows that both motifs are highly conserved across all 29,59-PE proteins (Fig. 2B, boxes) . These motifs form the catalytic core that binds to and cleaves the 2-5A substrate. Consistent with the phylogenetic analysis, sequence analysis revealed that the 29,59-PEs clustered into four groups corresponding to NS2, NS4b, AKAP7, and VP3. The two histidines within the conserved motifs were 100% conserved among all the sequences (Fig. 2B , asterisks). Several residues with an intergroup consensus of .50% were identified in the alignment. The amino acid alignment shows several regions of conservation that exist beyond the two conserved catalytic motifs (H-f -S/T-f ) (Fig. 2B , shown above the sequence alignment).

Among the sequences in the alignment, AKAP7 proteins of human, rat, and mouse origins shared the highest amino acid identity, ranging between 85 and 97% (88 to 97% similarity) (see Table S1 in the supplemental material). NS2 proteins shared 48 to 92% identity (64 to 94% similarity), NS4b proteins shared 35 to 49% identity (50 to 69% similarity), and VP3 proteins shared 16 to 78% identity (29 to 84% similarity) within their groups. Interestingly, while RVA VP3 proteins shared a high 78% identity (84% similarity) between them, they shared only 16% identity (29% similarity) with the representative of RVB VP3 proteins. The catalytic domains of 29,59-PEs have modest intragroup alignment and a relatively lower intergroup alignment. The overall intergroup alignment for the catalytic domains of these proteins showed 10 to 22% identity (19 to 36% similarity) (Table S1 ). NS2 proteins shared 11 to 16% amino acid identity (24 to 29% similarity) with NS4b, 16 to 22% identity (30 to 36% similarity) with AKAP7, and 16 to 22% identity (26 to 32% similarity) with VP3 proteins. Similarly, the NS4b group of proteins shared 12 to 18% identity (21 to 29% similarity) with AKAP7 and 10 to 19% identity (23 to 34% similarity) with VP3 proteins. AKAP7 and VP3 shared 11 to 20% identity and 19 to 25% similarity between the two groups.

29,59-PEs are specific for 29,59-linked phosphodiester bonds and preferably cleave 29,59-oligoadenylate. 29,59-PEs are members of the LigT family of the 2H-PE superfamily of enzymes, which are involved in RNA processing that can act on diverse substrates (19) . Also, members such as MERS-CoV NS4b and muAKAP7 have a functional NLS peptide (24, 27) . To determine if there was a wider role for these enzymes beyond cleaving 2-5A, we tested an expanded set of potential substrates. MERS-NS4b, MHV NS2, RVA VP3-CTD, and muAKAP7 proteins were expressed in bacteria and then purified. Also, for comparison, human PDE12 (also known as 29-PDE), a member of the exonuclease-endonuclease-phosphatase (EEP) family known to cleave 2-5A, was (32, 33) . The catalytically inactive mutant proteins MERS-NS4b H182R , MHV NS2 H126R , RVA VP3-CTD H718A , muAKAP7 H93A;H185R , and human PDE12 E351A served as the negative controls. The purity and identity of trimer 2-5A (29,59-p 3 A 3 ) were confirmed by high-performance liquid chromatography (HPLC) (Fig. 3A) and mass spectrometry (MS) (see Fig. 5J ). Purified 29,59-PE proteins were incubated with the 2-5A substrate at 30°C for 1 h, and the 2-5A cleavage products were analyzed by HPLC using a C18 column. All five wild-type proteins cleaved 2-5A as observed by the loss of intact 2-5A and the appearance of peaks for the different cleavage products (Fig. 3B to F) . Interestingly, MERS-NS4b (Fig. 3B ) and MHV NS2 (Fig. 3C ) degraded 2-5A to give two prominent products, whereas RVA VP3-CTD (Fig. 3D ) and muAKAP7 (Fig. 3E ) gave four products upon the extended degradation of 2-5A, suggesting a difference in either the mechanism or rate of cleavage by these proteins. On the other hand, 2-5A cleavage by human PDE12 (Fig. 3F ) results in the formation of two products corresponding to the elution time of the standards ATP and 59-AMP, as previously described (32) . As expected, the 29,59-PE catalytically inactive mutant proteins containing a His-to-Arg or His-to-Ala mutation in the conserved histidines did not cleave 2-5A ( Fig. 3G to J). Human PDE12 with a Glu-to-Ala mutation at amino acid residue 351 also did not degrade 2-5A, as described previously (34) (Fig. 3K) . Importantly, these findings show a different mode of 2-5A cleavage between 29,59-PEs, members of the 2H-PE superfamily, and PDE12, a member of the EEP family of phosphodiesterases.

To investigate the expanded substrate specificity of 29,59-PEs, we tested the possible cleavage of various 29-59-and 39-59-linked oligoribonucleotides by HPLC. Purified 29,59-PE proteins (1 mM) were incubated with either 29-59-or 39-59-linked pentaribonucleotide substrates (10 mM) at 30°C for 1 h. Wild-type MERS-NS4b specifically degraded 29-59 p59(rA) 5 by .99%, while 29-59 p59(rU) 5 , p59(C) 5 , or p59(G) 5 was not degraded (#4%) ( Table S2 ). The catalytically inactive mutant MERS-NS4b H182R did not degrade any of the tested substrates under similar conditions. Wild-type MHV NS2 also specifically degraded 29-59 p59(rA) 5 by .99%, while 29-59 p59(rU) 5 , p59(C) 5 , or p59(G) 5 was not degraded (#7%) ( Table S2 ). Mutant MHV NS2 H126R did not degrade any of the tested substrates. These results suggest that MERS-NS4b and MHV NS2 are remarkably specific in degrading 29-59-linked oligoadenylate compared to the other substrates. We further tested RVA VP3-CTD, which degraded 29-59 p59(rA) 5 at .95%, p59(rU) 5 at ;40%, p59(C) 5 at ;90%, and p59(G) 5 at ;6%, while mutant RVA VP3-CTD H718A did not degrade any of the tested substrates (Table S2) . Wild-type muAKAP7 degraded 29-59 p59(rA) 5 at .99%, p59(rU) 5 at .95%, p59(C) 5 at .95%, and p59(G) 5 at .90%, while mutant muAKAP7 H93A;H185R did not degrade any of the tested substrates with the exception of 29-59 p59(G) 5 at ;40% (Table S2 ). To ensure that the exclusive cleavage of 29, 59-oligoadenylates by MERS-NS4b was not due to limiting amounts of enzyme, 10 mM different 29,59-linked pentaribonucleotides was incubated with 3-fold-higher concentrations (3 mM) of MERS-NS4b at 30°C for 1 h. Wild-type MERS-NS4b specifically degraded 29-59 p59(rA) 5 by .99%, while 29-59 p59(rU) 5 , p59(C) 5 , or p59(G) 5 was not degraded (#6%), suggesting that MERS-NS4b enzymatic activity is specific for the degradation of 29,59-oligoadenylates (Table S3 ). Because MERS-NS4b and MHV NS2 cleaved 29-59 p59(rA) 5 but not other 29-59-linked substrates, we further determined if this was due to a lack of binding to the other substrates. To test this possibility, 10 mM 29-59 p59 (rA) 5 was incubated with 0.2 mM MHV NS2 in the absence or presence of increasing concentrations of 29-59 p59(rU) 5 at 30°C for 10 min. The amounts of 29-59 p59(rA) 5 degraded by MHV NS2 in the presence of 0, 3.1, 10, 12.5, 25, 50, and 100 mM were determined by HPLC analysis (Fig. S1 ). Degradation of 29-59 p59(rA) 5 by MHV NS2 

® decreased as the amount of 29-59 p59(rU) 5 in the reaction mixture increased beyond 10 mM (i.e., ratio of .1:1) (Fig. S1 ). Our results suggest that 29-59 p59(rU) 5 was able to bind MHV NS2 and competitively interfere with the ability of MHV NS2 to cleave 29-59 p59(rA) 5 .

We next tested the degradation activity of 29,59-PEs against 39-59-linked p59(rA) 5 , p59(rU) 5 , and p59(C) 5 . One micromolar enzyme was incubated with 10 mM the substrate at 30°C for 1 h. Wild-type MERS-NS4b and its mutant MERS-NS4b H182R , wild-type MHV NS2 and its mutant NS2 H126R , RVA VP3-CTD and its mutant RVA VP3-CTD H718A , and wildtype muAKAP7 and its mutant muAKAP7 H93A;H185R (Table S2 ) did not degrade the 39-59linked substrates 39-59 p59(A) 5 , 39-59 p59(U) 5 , and 39-59 p59(C) 5 . [We were unable to obtain 39-59 p59(G) 5 because of repeated failures of its chemical synthesis and/or purification; therefore, this oligonucleotide could not be tested]. Our results suggest that all of the 29,59-PEs examined are highly specific for cleaving 29,59-linked oligoribonucleotides. Among the 29,59-linked substrates, MERS-NS4b and MHV NS2 are specific for cleaving 29-59-oligoadenylate, whereas RVA VP3-CTD cleaved, in order, 29-59 pA5 . pC5 . pU5 ) pG5, and muAKAP7 cleaved all of the 29,59-linked pentanucleotides with similar efficacy.

Based on the differential enzymatic activities of these 29,59-PEs in degrading different types of 29,59-linked phosphodiester substrates, we tested if they could degrade 29,39-cyclic GMP-AMP (cGAMP). cGAMP is a cyclic dinucleotide secondary messenger with mixed phosphodiester linkages between 29-OH of GMP to the 59-phosphate of AMP and 39-OH of AMP to the 59-phosphate of GMP, synthesized by cyclic GMP-AMP synthase (cGAS) in response to cytoplasmic double-stranded DNA (dsDNA) (35) . cGAMP was incubated either with or without wild-type and mutant 29,59-PEs at 30°C for 1 h and analyzed by HPLC. Wild-type MERS-NS4b, MHV NS2, RVA VP3-CTD, and muAKAP7 did not degrade 29,39-cGAMP, whereas they did degrade 29,59-p 3 A 3 (which served as a positive control) under similar conditions (Table S4 ). Catalytic mutants of 29,59-PEs tested did not degrade 29,39-cGAMP or 29,59-p 3 A 3 under similar conditions. The results suggest that 29,59-PEs are capable of cleaving 29,59-phosphodiester bonds in linear homoribonucleotides but not in the cyclic mixed-phosphodiester-linked 29,39-cGAMP.

29,59-PEs exhibit metal ion-independent phosphodiesterase activity. Metal ion dependency was evaluated by performing assays in the presence of either EDTA or magnesium. In the presence of EDTA, without added magnesium, 1 mM MERS-NS4b Based on the specific activities, the ratio of fold activities of RVA VP3-CTD: muAKAP7: MERS-NS4b: MHV NS2 was 38.9:2.9:1:1. It is noteworthy that many mammalian cell types have a total cellular Mg 21 concentration of between 17 and 20 mM, of which only 5 to 22% may be free depending on the cellular compartment (36) . We determined the specific activities of the 29,59-PEs for degrading 2-5A in the absence and presence of 10 mM MgCl 2 at 5 min (Fig. 4E ). The addition of Mg 21 ions decreased the specific activity of MERS-NS4b to ;0.6-fold and that of muAKAP7 to ;0.8-fold. The activities of MHV NS2 and RVA VP3-CTD showed a negligible decrease to 0.97-fold and 0.99-fold in the presence of Mg 21 ions, respectively. Our results suggest that the 29,59-PE activity of these proteins is independent of Mg 21 ions and that its presence either slightly decreases or has no effect on the activity of these enzymes.

29,59-PEs cleave 29,59-linked oligoadenylate leaving products with cyclic 29,39phosphoryl termini. Differences in the 2-5A cleavage products as determined by HPLC (Fig. 3) suggested that viral and mammalian 29,59-PEs cleave 2-5A via a different mechanism than that of human PDE12, which degrades 2-5A to produce ATP and AMP (32) . Among 29,59-PEs, MERS-NS4b and MHV NS2 degraded 2-5A to give two cleavage products, whereas RVA VP3-CTD and muAKAP7 gave four cleavage products. Therefore, we decided to determine the precise sites of cleavage in 2-5A by 29,59-PEs. Partial digestion of 2-5A by MERS-NS4b was confirmed by HPLC analysis of the samples using a C18 column (Fig. 5B ) and comparing it with the chromatogram of intact 2-5A (Fig. 3A) . The 2-5A partially digested by MERS-NS4b was run on a Dionex DNAPac PA-100 column in an ammonium bicarbonate volatile buffer system as described in Materials and Methods. Individual peaks were collected and processed for mass spectrometry analysis. Individually collected peaks were also rerun on a C18 column to confirm the purity and matched elution times of the collected peaks before performing LC-MS/MS analysis ( Fig. 5C and D) . Mass spectrometric analysis of the peaks revealed m/z ratios of 597.25 (Fig. 5H ) and 570.4 (Fig. 5I) . The m/z ratios of 597.25 and 570.4 were compared to the masses of potential 2-5A degradation/intermediate products (Fig. 5G) and were found to correspond to ApA and p 3 A.p (where ".p" represents a 29,39-cyclic phosphate), respectively. Intact 2-5A gave an m/z ratio of 584 for the doubly Table showing the specific activity of 29,59-PEs in the absence and presence of 10 mM MgCl 2 . Activity is expressed as the amount of product released from the substrate in nanomoles per minute per milligram of the protein at 30°C during a 5-min reaction time. Experiments were performed in triplicate (n = 3), and the standard errors of the means were calculated. Two-Histidine Phosphoesterases ® charged ion (Fig. 5J) . Moreover, the collected peak of p 3 A.p (shown in Fig. 5D ) was subjected to shrimp alkaline phosphatase (SAP)-mediated 59 dephosphorylation, which results in the peak corresponding to A.p ( Fig. 5E and F) . This experiment suggested that MERS-NS4b degrades 2-5A to produce a 59 product with a 29,39-cyclic phosphate Two-Histidine Phosphoesterases ® unchanged up to 24 h. Also, 29-59-linked 59pApA incubated with MERS-NS4b did not result in any degradation (Fig. S2E to I) . These results suggest that MERS-NS4b does not cleave diadenylates into smaller products irrespective of the 59-monophosphorylation status under the given experimental conditions.

With a similar approach, we designed an experiment to elucidate the cleavage products and intermediates formed upon 2-5A degradation by RVA VP3-CTD (Fig. 6A) . Because RVA VP3-CTD has high specific activity against 2-5A (Fig. 4) , 2-5A was incubated with decreased protein concentrations and times of incubation to capture any possible intermediates and degradation products of 2-5A ( Fig. 6B and C) . 2-5A cleaved by VP3-CTD forms products, which, based on the elution times of the known standards and compounds, were identified as p 3 A.p, A.p, ApA, adenosine, and an unknown intermediate (shown in gray) (Fig. 6C) . Based on the potential degradation intermediates, we speculated that the unknown intermediate was p 3 ApA.p. To test this possibility, a part of the sample reaction mixture with 2-5A cleavage products (obtained from the sample used in Fig. 6C ) was subsequently treated with SAP to remove 59 phosphorylation from the cleavage products (if any), which would result in the formation of A.p and ApA.p from p 3 A.p and p 3 ApA.p, respectively (Fig. 6E ). The dephosphorylated sample was analyzed by running it on a C18 column. After SAP treatment, the amounts of adenosine and ApA remained constant compared to those before (Fig. 6C) and after ( Fig. 6D ) dephosphorylation, as calculated by integrating the areas under the peaks of the HPLC chromatograms. However, the total area under the peak corresponding to A.p increased, suggesting that A.p was formed as a result of the dephosphorylation of p 3 A.p ( Fig. 6C and D) . Importantly, a new peak (possibly ApA.p) appears, which is formed by the dephosphorylation of an unknown intermediate (Fig. 6D , shown in gray). The dephosphorylated samples were run on a Dionex DNAPac PA-100 column in an ammonium bicarbonate volatile buffer system as described in Materials and Methods. Individual peak fractions were collected and processed for mass spectrometry analysis. Collected peaks were rerun on a C18 column to confirm the purity and match the elution time of the collected peak with those of A.p and the "dephosphorylated intermediate" (Fig. 6D ) before performing LC-MS/MS. Mass spectrometric analysis of the peaks revealed m/z ratios of 330, corresponding to A.p (Fig. 6F) , and 659.1, which corresponds to ApA.p (Fig. 6G) . This experiment suggests that trimer 2-5A (29,59p 3 A 3 ) degradation by RVA VP3-CTD proceeds via the formation of p 3 ApA.p and ApA intermediates. RVA VP3-CTD degrades p 3 ApA.p to form p 3 A.p (59 product) and A.p (39 product), whereas diadenylate (ApA) is further degraded to yield A.p (59 product) and adenosine (39 product). The complete degradation of p 3 A 3 by RVA VP3-CTD results in the formation of p 3 A.p, A.p, and adenosine as end products (Fig. 3D) . Furthermore, the preferred site of p 3 A 3 cleavage by RVA VP3-CTD was investigated in a time course experiment. RVA VP3-CTD (0.05 mM) was incubated with the p 3 A 3 (200 mM) substrate at 30°C, and samples were collected at different time points. The substrate or product peaks at each time point were analyzed by calculating the percentages of the areas under the peaks of the HPLC chromatograms (Fig. S3) and tabulated (Fig. S4A) . The analysis revealed that the majority of p 3 A 3 is cleaved by RVA VP3-CTD to produce p 3 ApA.p (59 product) and adenosine (39 product). The intermediate species (p 3 ApA.p) is subsequently cleaved to produce p 3 A.p (59 product) and A.p (39 product). A minor fraction of p 3 A 3 is cleaved by RVA VP3-CTD to produce p 3 A.p (59 product) and ApA (39 product). The diadenylate intermediate (ApA) is subsequently cleaved into A.p (59 product) and adenosine (39 product) (Fig. S4B) , which is apparent from incubations at a higher concentration of RVA VP3-CTD (Fig. 3D) . Moreover, the degradation pattern of the two diadenylate intermediates reveals that a triphosphorylated intermediate (p 3 ApA.p) is readily cleaved by RVA VP3-CTD, whereas ApA cleavage is slow, suggesting that 59-triphosphorylated molecules are preferred over nonphosphorylated substrates (Fig. S3 and S4) . In a separate experiment, 10 mM 29-59-linked 59p(A) 2 was incubated with 1 mM VP3-CTD at 30°C for 1 h. The results confirmed the formation of cleavage products corresponding to pA.p (59 product) and adenosine (39 product) (Fig. S5) . Moreover, in another time course experiment, muAKAP7 cleaved p 3 A 3 to produce p 3 A.p (59 product) and ApA (39 product) (Fig. S6) . The ApA intermediate was further cleaved to form A.p and adenosine. Interestingly, unlike RVA VP3-CTD, muAKAP7-mediated cleavage of p 3 A 3 does not form a p 3 ApA.p intermediate.

The overall mechanisms and differences in the degradation of 2-5A by representative EEP (PDE12) and 29,59-PE family members are summarized in Fig. 7 . Human PDE12 degrades trimer 2-5A into ATP and 2(59-AMP)s in the presence of Mg 21 ions, as has been reported previously (32) . On the other hand, mammalian and viral 29,59-PEs act in Two-Histidine Phosphoesterases ® a metal ion-independent way, degrading 2-5A to form 59 products with 29,39-cyclic phosphates. All 29,59-PEs quickly cleave active antiviral 2-5A into inactive molecules; that is, the products are not capable of activating RNase L because of a requirement for at least 3 adenylyl residues (37) . MERS-NS4b and MHV NS2 degrade trimer 2-5A to form p 3 A.p and ApA. RVA VP3-CTD and muAKAP7 further cleave ApA to form A.p and adenosine as products. In addition to the above-mentioned degradation intermediates and products of 2-5A, RVA VP3-CTD also produced p 3 ApA.p as an intermediate, suggesting that it is a 29,59-specific endoribonucleolytic phosphodiesterase ( Fig. 6 and 7) .

Cleavage specificity and mechanism of 29,59-PEs. The 29,59-PEs studied here exclusively cleaved 29,59-and not 39,59-phosphodiester bonds. There was also a strong preference for the cleavage of 29,59-oligoadenylates by NS2, NS4b, and, to a lesser extent, VP3-CTD, whereas AKAP7 had similar activities against the different 29,59-linked pentamers of A, U, C, and G. Therefore, although AKAP7 and VP3-CTD are not the most closely related 29,59-PEs, they can both cleave 29,59-oligoribonucleotides other than 2-5A ( Fig. 2A ; see also Table S2 in the supplemental material). Interestingly, OASs are 29nucleotidyltransferases that not only use ATP as the substrate but also can produce diverse molecules with 29,59 linkages. NAD 1 , tRNAs, A59p 4 59A, and mono-and poly-ADP-ribose are acceptors for the addition of 29,59-AMP residues from ATP by OAS. Also, OAS can add other 29-terminal ribo-and deoxynucleotide monophosphates to 2-5A (38) (39) (40) (41) . However, which, if any, of these alternative 2-5A-like molecules can be cleaved by 29,59-PEs remains to be determined. cGAMP, a cyclic dinucleotide that activates STING, has one 29,59 linkage and one 39,59 linkage, but it is not cleaved by the 29,59-PEs examined here (Table S4 ). VP3 was phylogenetically distal and has the most distinct mechanism of 2-5A cleavage compared to all of the tested 29,59-PEs. It is also interesting to note that the two coronavirus 29,59-PEs (NS4b and NS2) are less closely related than NS2 is to the host enzyme AKAP7 ( Fig. 2A and Table S1 ). Our results suggest that the main, and perhaps only, function of these activities is to degrade 2-5A, thus preventing RNase L activation and viral escape or, in the case of AKAP7, reducing cell and tissue damage from RNase L activity. These 29,59-PEs are also metal ion-independent enzymes, as is RNase L (42) .

The viral and mammalian 29,59-PEs produce cleavage products from trimer 2-5A (29,59-p 3 A 3 ) with cyclic 29,39-phosphoryl groups and not 29,39-OH termini. These conclusions are based on analysis of 2-5A cleavage products by two types of HPLC columns (Dionex and C18) and, importantly, by mass spectrometry. In contrast, our previous studies based on a more limited analysis of the 2-5A cleavage products by one type of HPLC column (Dionex) misidentified these cleavage products of NS2, VP3-CTD, and AKAP7 as AMP and ATP (22, 25, 27) .

Interestingly, mammalian and viral 29,59-PEs have activities highly similar to those of an invertebrate 2H-PE present in the oyster Crassostrea gigas (43) . The oyster enzyme has sequence similarity to AKAP7, is metal ion independent, cleaves 29,59-but not 39,59-linked oligonucleotides, and leaves cyclic 29,39-phosphate and 59-OH termini on its products. It also degraded triphosphorylated 2-5A oligomers with multifold efficiency compared to the corresponding nonphosphorylated core 2-5A oligomers. Similarly, we observed that RVA VP3-CTD degrades 59-triphosphorylated diadenylate with 29,39-cyclic phosphoryl termini (p3ApA.p) preferentially compared to the nonphosphorylated diadenylate (ApA) core molecule (Fig. S3 and S4) . However, the function and role of 2-5A-cleaving enzymes in invertebrates are still unknown.

It is also unknown if the 29,39-cyclic phosphates on 2-5A breakdown products generated by 29,59-PEs have cell signaling functions. However, small self-RNAs with 29,39cyclic phosphate termini (generated by RNase L) induced IFN-b expression through RIG-I, MDA5, and MAVS (44) . Additionally, RNase L-cleaved RNA with 29,39-cyclic phosphates stimulated the NLRP3 inflammasome, leading to interleukin-1b (IL-1b) secretion (15) . Also, during Staphylococcus aureus infections, RNase T2 cleaves singlestranded RNA (ssRNA), producing purine-29,39-cyclic phosphate-terminated oligonucleotides sensed by Toll-like receptor 8 (TLR8) (45) . The mammalian enzyme USB1, another 2H-PE, also produces 29,39-phosphoryl termini during the deadenylation of U6 snRNA, but it clearly differs from the 29,59-PEs because it cleaves 39,59-phosphodiester bonds (21) .

2-5A catabolism during IFN-induced cellular responses to viral and host dsRNA. The ability of viruses to evade or antagonize the IFN response contributes to viral tropism and disease pathogenesis. Accordingly, viruses have evolved or acquired diverse strategies to overcome inhibition by type I and type III IFNs, both of which induce the transcription of OAS genes (1, 2, 46) . However, the precise cellular and molecular mechanisms by which viruses impede tissue-specific host defenses leading to virus-induced pathology continue to be investigated. With regard to the OAS-RNase L pathway, it is the balance between 2-5A anabolic (OAS) and catabolic (e.g., 29,59-PEs and PDE12) (20) activities that determines whether virus replication is blocked by RNase L. For instance, RNase L fails to inhibit the coronaviruses MHV and MERS-CoV or rotaviruses, unless there is an inactivating mutation of their 2-5A-degrading enzymes (NS2, NS4b, and VP3, respectively) (22, (24) (25) (26) . In contrast, SARS-CoV-2, which lacks a gene for a similar protein, is inhibited by RNase L (4). In this context, enzymes that degrade 2-5A, such as PDE12, are drug targets in the hunt for broad-spectrum antiviral agents (32, 47) .

The viral enzymes NS2, NS4b, and VP3-CTD are antagonists of innate immunity that support virus replication by eliminating 2-5A and preventing, or reducing, the activation of RNase L by 2-5A (20, 22, (24) (25) (26) . In contrast, mammalian AKAP7 is a nuclear 29,59-PE that does not affect viral replication unless its nuclear localization signal peptide is deleted, leading to cytoplasmic accumulation (27) . A mutant AKAP7 deleted for its N-terminal nuclear localization signal peptide accumulates in the cytoplasm and was able to rescue an NS2 mutant of MHV (22) . While the function of the 29,59-oligonucleotide-cleaving activity of AKAP7 is still unresolved, the phylogenetic tree suggests that the NS2 coronavirus proteins may have evolved from the AKAP7 catalytic domain ( Fig. 2A) .

Enzymes that degrade 2-5A have significance beyond antiviral innate immunity. Self-dsRNA activates the OAS-RNase L pathway, leading in some circumstances to apoptosis (12, 13) . In one example, mutation or inhibition of the dsRNA editing enzyme ADAR1 leads to the accumulation of self-dsRNA activating OAS-RNase L, leading to cell death, and protein kinase R (PKR), inhibiting protein synthesis initiation (16, 48) . In another instance, DNA methyltransferase inhibitors, e.g., 5-aza-cytidine, cause self-dsRNA accumulation from repetitive DNA elements, leading to OAS-RNase L activation and apoptosis (17, 49) . Thus, 2-5A is a secondary messenger for cytotoxic and antiviral activities of either nonself dsRNA (viral) or self-dsRNA (host), whose levels must be tightly controlled to limit cytotoxicity while restricting viral spread. Our findings provide a mechanistic understanding of how 29,59-PEs regulate 2-5A levels among the coronaviruses MHV and MERS-CoV, group A rotaviruses, and mammalian cells through the activity of AKAP7 (22, 24, 25, 27) , with implications for both the control of virus replication and cellular responses to self-dsRNA. Furthermore, our study defines 29,59-PEs as a new subgroup within the 2H-PE superfamily that shares characteristic conserved sequence features of the superfamily but with specific and distinct biochemical cleavage activities. Knowledge derived from the study of these 2-5A-degrading enzymes could lead to future avenues of antiviral drug development.

cDNA cloning and plasmids. Human PDE12 cDNA (GenBank accession number NM_177966.5) was PCR amplified (using DNASU cDNA clone HsCD00296464 in vector pDONR221) with forward primer 59-TTCAAgaattcATGTGGAGGCTCCCAGGCGC-39 (with an EcoRI restriction site [in underlined lowercase type]) and reverse primer 59-TTCAAgtcgacTCATTTCCATTTTAAATCACATACAAGTGCTATGTGATC-39 (with a SalI restriction site [in underlined lowercase type]). The PDE12 E351A pGEX 6P-1 mutant (34) plasmid was constructed by the MegaPrimer method (50) using mutagenic reverse primer 59-GCGCGGTCAACCgCCTGCAAACAG-39, where "g" Two-Histidine Phosphoesterases ® represents mutated nucelotide. The amplified wild-type and mutant PDE12 cDNAs were cloned into plasmid pGEX-6P-1 (GE Healthcare, USA) at the EcoRI and SalI restriction site, sequenced, and expressed in Escherichia coli as glutathione S-transferase (GST) fusion proteins. To subclone the VP3 C-terminal domain (CTD) cDNA of rotavirus A strain RVA/Simian-tc/USA/RRV/1975/G3P (GenBank accession number EU636926.1) and its H718A mutant, we used codon-optimized constructs for expression in Sf9 insect cells (GenBank accession number KJ869109.1) (30) (cDNA tempelates were gifts from Kristin Ogden, Vanderbilt University). The cDNAs were PCR amplified and cloned into plasmid pMAL-C5X at the XmnI (blunt cloned) and NcoI (sticky end) restriction sites. Blunt-end forward primer 59-TACGCTGACGACCCCAACTACTTCATCG-39 and reverse primer 59-TTCAA ccatggTTATTACTCGGACATGTCGAACACGGTGTCG-39 with an NcoI restriction site (in underlined lowercase type) were used for VP3-CTD. The wild-type and H718A RVA VP3-CTD proteins were expressed as fusions to maltose binding protein (MBP). Additional protein expression plasmid constructs were previously described, with sequences originating from MERS-CoV (MBP-NS4b and its mutant MBP-NS4b H182R ) (24), MHV (MBP-MHV NS2 and its mutant MBP-NS2 H126R ) (22) , and mouse AKAP7 and its mutant AKAP7 H93A;H185R (27) .

Protein expression and purification. Proteins were expressed from pGEX-6P-1 or pMAL constructs in E. coli strain BL21(DE3)/pLysS (Life Technologies, USA). Wild-type and catalytically inactive mutants of AKAP7 and PDE12 were expressed as GST fusion proteins, and purification was performed by modification of a previous protocol (51) . Single colonies were used to inoculate primary cultures, which were subsequently used to seed secondary cultures grown to an optical density (OD) (at 600 nm) of 0.6 in a shaking incubator at 37°C at 250 rpm. Cells were induced with 0. . Pelleted cells were lysed by the addition of 200 mg/ml lysozyme, followed by sonication. Supernatants were collected after centrifugation at 12,000 Â g for 40 min at 4°C in a Beckman JA-17 rotor. Supernatants were added to Pierce glutathione agarose (Thermo Scientific, USA) and incubated for 2 h at 4°C, followed by washes with buffer A. Digestions to release the GST tag were performed with PreScission protease (Cytiva, USA) in a solution containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, and 1 mM DTT for 16 h at 4°C. Supernatants containing untagged protein were concentrated using Centriprep centrifugal filter devices (molecular weight cutoff of 10 kDa; Millipore) and loaded onto a Superdex 75 column on an Äkta pure 25L protein purification system (GE Healthcare, USA) in a solution containing 20 mM HEPES (pH 7.5), 150 mM NaCl, and 1 mM DTT. Wild-type and mutant RVA VP3-CTD-expressing bacterial culture growth and IPTG induction conditions were the same as the ones described above, except that growth medium additionally included 2% glucose. Harvested bacterial cell pellets were suspended in buffer B (20 mM Tris-HCl [pH 7.4] with 200 mM NaCl, 1 mM EDTA, 10 mM b-mercaptoethanol, an EDTA-free protease inhibitor [Pierce protease inhibitor; Thermo Scientific, USA], and 10% glycerol) and lysed with lysozyme, followed by sonication. Supernatants were incubated with amylose resin (New England BioLabs [NEB], USA) and washed three times with buffer, followed by elution with 100 mM maltose. Proteins were concentrated using Centriprep centrifugal filter devices (molecular weight cutoff of 10 kDa; Millipore) and further purified using size exclusion chromatography (SEC) on an Äkta pure 25L protein purification system (GE Healthcare, USA) in buffer C (20 mM HEPES [pH 7.5], 100 mM NaCl, and 1 mM DTT). Wild-type and catalytic mutants of NS4b and MHV NS2 were purified as described previously (22, 24) . In addition to inactive mutants, purified MBP was used as the control in experiments with MBP fusion proteins. Protein concentrations were determined using the Bio-Rad protein assay reagent (Bio-Rad, USA). All proteins were stored in buffer C supplemented with 10% glycerol at 280°C.

Synthesis and purification of 2-5A oligomers and other oligoribonucleotide substrates. 2-5A or p 3 59A(29p59A) 2 (29,59-p 3 A 3 ) was synthesized from ATP by using histidine-tagged porcine OAS1 (52) . The OAS was immobilized and activated with poly(I):poly(C)-agarose (53) . Briefly, poly(I):poly(C)-agarose beads were washed with buffer D [10 mM HEPES (pH 7.5), 1.5 mM Mg(CH 3 COO) 2 Á4H 2 O, 50 mM KCl, 20% glycerol, and 7 mM b-mercaptoethanol]. Ten milliliters of beads was incubated with 10 mg of purified OAS protein for 2 h at 25°C, with intermittent vortexing. Beads were washed three times with buffer D by centrifugation at 3,000 Â g at 4°C for 30 min. Beads were suspended in reaction mixtures containing 20 mM HEPES (pH 7.5), 20 mM Mg(CH 3 COO) 2 Á4H 2 O, 20 mM KCl, 1 mM EDTA, and 10 mM ATP. The reaction mixtures were incubated in a shaking incubator set at 37°C at 120 rpm for 18 h. The supernatant was collected by centrifugation at 3,000 Â g at 4°C for 30 min. The supernatant was heated at 95°C for 5 min and again centrifuged at 18,000 Â g for 15 min at 4°C to remove the precipitate. To isolate individual 2-5A oligomers, the supernatants containing crude, unfractionated 2-5A oligomers were run on an HPLC instrument (1260 Infinity II; Agilent Technologies) equipped with a preparative Dionex column (BioLC DNAPac PA-100, 22 by 250 mm; Dionex, USA). Samples were injected and elution was performed at a flow rate of 3 ml/min in a stepwise gradient of 10 to 400 mM (0 to 120 min), 400 to 800 mM (121 to 125 min), and 10 mM (126 to 160 min) NH 4 HCO 3 buffer (pH 7.8). Fractions were collected, lyophilized, and suspended in nuclease-free water.

RNA oligoribonucleotides (other than 29,59-p 3 A 3 ) with 29-59-or 39-59-phosphodiester linkages were commercially purchased. The oligonucleotide substrates 59-pA29p59A29p59A29p59A29p59A-39, 59-pU29 p59U29p59U29p59U29p59U-39, 59-pG29p59G29p59G29p59G29p59G-39, 59-pA39p59A39p59A39p59A39p59A-39, and 59-pU39p59U39p59U39p59U39p59U-39 were purchased from Integrated DNA Technologies (IDT), while 59-pC29p59C29p59C29p59C29p59C-39, 59-pC39p59C39p59C39p59C39p59C-39, and 59-pA29p59A-39 were purchased from ChemGenes Corporation (Wilmington, MA, USA). Pentaribonucleotide substrates are shown as p59(rN) 5 , where N represents an A, U, G, or C nucleotide. The A29p59A standard was prepared by incubating 59pA29p59A with shrimp alkaline phosphatase (SAP; Thermo Fisher, USA) according to the manufacturer's protocol. 29,39-Cyclic GMP-AMP (cGAMP), ATP, AMP, and adenosine were obtained from Sigma-Aldrich.

Phosphodiesterase activity assays. A total of 10 mM the substrates (with either a 29-59-or 39-59phosphodiester linkage) was incubated with 1 mM enzyme. Final reactions were performed in a solution containing 20 mM HEPES buffer (pH 7.4), 1 mM DTT, and 10 mM MgCl 2 by incubation at 30°C for 1 h (or for the time indicated in the text). Where indicated, reactions were performed in the absence of MgCl 2 with 2 mM EDTA added. Reactions were stopped by heating at 95°C for 5 min. Samples were centrifuged at 18,000 Â g for 15 min at 4°C. Supernatants were collected and analyzed by HPLC. 29,39-cGAMP degradation assays were performed and analyzed under the same conditions as the ones described above. In all experiments, substrates incubated under similar conditions in the absence of enzyme served as controls.

HPLC analysis and identification of products. The substrates and cleavage products were analyzed on a 1260 Infinity II Agilent Technologies HPLC instrument equipped with an Infinitylab Poroshell 120 C 18 analytical column (4.6 by 150 mm, 4 mm; Agilent Technologies). Eluent A was 50 mM ammonium phosphate buffer (pH 6.8), and eluent B was 50% methanol in water. Five microliters of processed samples was injected onto the C 18 column, at a flow rate of 1 ml/min, and eluted with a linear gradient (0 to 40%) of eluent B over a period of 20 min and then 3 min of 40% eluent B, followed by equilibration to initial conditions (100% eluent A). The HPLC column was maintained at 40°C. Spectra were recorded at 256 nm. The products were identified either by comparison to the elution times of known standards or by mass spectrometry analysis. Alternatively, to test expanded substrate specificity, 10 ml of the processed samples was injected onto a Dionex DNAPac PA-100 analytical column at a flow rate of 1 ml/min and eluted with a linear gradient of 10 to 800 mM NH 4 HCO 3 buffer (pH 7.8) over a period of 90 min, followed by 30 min of equilibration to initial conditions. Open Lab CDS software was used to analyze and calculate the areas under the peaks in HPLC spectra.

Shrimp alkaline phosphatase-mediated phosphorylation analysis. Purified substrates and cleavage product mixtures were dephosphorylated by incubation with SAP (Thermo Fisher, USA) at 37°C for 1 h according to the manufacturer's protocol. Samples were prepared for subsequent analysis as described above.

Sample preparation for mass spectrometry. The desired peak fractions (including cleavage products of 29,59-p 3 A 3 ) were collected by running samples on a Dionex DNAPac PA-100 analytical column as described above. The collected peaks were subjected to acetone precipitation, and supernatants containing cleavage products (from the HPLC peak) were collected and lyophilized. Lyophilized samples were suspended in 1 mM NH 4 HCO 3 buffer (pH 7.8) and used for mass spectrometry analysis.

Mass spectrometry analysis of cleavage products. The prepared samples were subjected to mass spectrometry analysis. The LC-MS/MS analysis was carried out using a triple-quadrupole tandem mass spectrometer (TSQ-Quantiva; Thermo Scientific, USA) equipped with an electrospray ionization (ESI) interface. The mass spectrometer was coupled to the outlet of the HPLC system that consisted of an ultrahigh-performance liquid chromatography (UHPLC) system (Vanquish; Thermos Fisher Scientific, USA) including an autosampler with a refrigerated sample compartment and an inline vacuum degasser. Xcalibur software was used for data processing. ESI mass spectrometric detection was performed in both the negative and positive ionization modes, with an ion spray voltage at 2.5 kV, sheath gas at 35 Arb (arbitrary relative unit for measurement of gas flow), and auxiliary (Aux) gas at 20 Arb. The ion transfer tube and vaporizer temperatures were set at 350°C and 250°C, respectively. Qualitative analysis was performed using a full scan at a range from m/z 200 to 1,250. Five-microliter extracted samples were injected onto the C 18 column (Gemini, 3 mm, 2 by 150 mm; Phenomenex, CA) with a flow rate of 0.3 ml/ min at 45°C. Mobile phases were mobile phase A (water containing 10 mM ammonium acetate and 20 mM ammonium hydroxide) and mobile phase B (methanol containing 10 mM ammonium acetate and 20 mM ammonium hydroxide). Mobile phase B at 0% was used at 0 to 2 min, and linear gradients were used starting from 0% mobile phase B to 100% B at 2 to 12 min and kept at 100% at 12 to 26 min and then from 100% B to 0% B at 26 to 27 min and kept at 0% mobile phase B for 8 min. The peaks shown in full scans were processed to locate and identify the cleavage products of the 29,59-p 3 A 3 substrate using Xcalibur software v4.1. The standards adenosine, AMP, ATP, and adenosine-29,39-cyclic monophosphate sodium salt were run for reference.

Bioinformatic analysis. The PDE domain sequences from different 29,59-PEs were used for creating a multiple-sequence alignment using MAFFT (Multiple Alignment using Fast Fourier Transform) version 7 (54) , employing the E-INS-I iterative refinement method (https://mafft.cbrc.jp/alignment/server/). The MAFFT sequence alignment result was downloaded in Clustal format and visualized using Jalview 2.11.1.3 software. The sequence alignment was further processed on the MAFFT server to calculate the phylogenetic tree using the neighbor-joining method and the JTT (Jones-Taylor-Thornton) substitution model, and the tree was then visualized using Archaeopteryx.js software. The resultant fasta format output of the MAFFT multiple-sequence alignment was used to calculate the percentages of amino acid identity and similarity by the Sequence Identity and Similarity (SIAS) tool with default parameters (http://imed. Data availability. Multiple-sequence alignment software is available at https://mafft.cbrc.jp/ alignment/server/. The alignment and phylogenetic tree construction tool is downloadable from https:// www.jalview.org/. The Sequence Identity and Similarity (SIAS) tool with default parameters is available at http://imed.med.ucm.es/Tools/sias.html. The names (accession numbers) of the aligned sequences are MHV NS2 (UniProtKB/Swiss-Prot accession number P19738.1), HCoV OC43 NS2 (GenBank accession number AAT84352.1), HECoV NS2 (GenBank accession number ACJ35484.1), ECoV NS2 (GenBank accession number ABP87988.1), MERS-CoV NS4b (GenBank accession number AFS88939.1), rat AKAP7d /g (NCBI RefSeq accession number NP_001001801.1), mouse AKAP7 isoform 1 (NCBI RefSeq accession number NP_061217.3), human AKAP7g (NCBI RefSeq accession number NP_057461.2), human RVA WA VP3 (GenBank accession number AFR77808.1), simian RVA SA11 N5 (GenBank accession number AFK09591 .1), human RVB Bang117 (GenBank accession number ADF57896.1), BtCoV SC2013 NS4b (GenBank accession number AHY61340.1), and BtCoV HKU5 NS4b (NCBI RefSeq accession number YP_001039965.1).

Supplemental material is available online only. 

Interferons at age 50: past, current and future impact on biomedicine

Antiviral actions of interferons

Forty years with coronaviruses

SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells

pppA29p59A29p59A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells

The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities

Genomic structure of the mouse 29,59-oligoadenylate synthetase gene family

Activation of RNase L in Egyptian Rousette bat-derived RoNi/7 cells is dependent primarily on OAS3 and independent of MAVS signaling

Inhibition of cell-free protein synthesis by pppA29p59A29p59A: a novel oligonucleotide synthesized by interferontreated L cell extracts

Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action

A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system

Interferon action and apoptosis are defective in mice devoid of 29,59-oligoadenylate-dependent RNase L

RNase L activates the NLRP3 inflammasome during viral infections

Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line

OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug

Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency

Detection of novel members, structure-function analysis and evolutionary classification of the 2H phosphoesterase superfamily

Viral phosphodiesterases that antagonize double-stranded RNA signaling to RNase L by degrading 2-5A

Structural and mechanistic basis for preferential deadenylation of U6 snRNA by Usb1

Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology

Lineage A betacoronavirus NS2 proteins and the homologous torovirus Berne pp1a carboxyterminal domain are phosphodiesterases that antagonize activation of RNase L

Middle East respiratory syndrome coronavirus NS4b protein inhibits host RNase L activation

Homologous 29,59-phosphodiesterases from disparate RNA viruses antagonize antiviral innate immunity

Reverse genetics reveals a role of rotavirus VP3 phosphodiesterase activity in inhibiting RNase L signaling and contributing to intestinal viral replication in vivo

Murine AKAP7 has a 29,59-phosphodiesterase domain that can complement an inactive murine coronavirus ns2 gene

MERS-CoV 4b protein interferes with the NF-kappaB-dependent innate immune response during infection

Rotavirus open cores catalyze 59-capping and methylation of exogenous RNA: evidence that VP3 is a methyltransferase

Predicted structure and domain organization of rotavirus capping enzyme and innate immune antagonist VP3

Analysis of rotavirus species diversity and evolution including the newly determined fulllength genome sequences of rotavirus F and G

Identification of 29-phosphodiesterase, which plays a role in the 2-5A system regulated by interferon

Characterization of human phosphodiesterase 12 and identification of a novel 29-59 oligoadenylate nuclease-the ectonucleotide pyrophosphatase/phosphodiesterase 1

PDE12 removes mitochondrial RNA poly(A) tails and controls translation in human mitochondria

Molecular mechanisms and cellular functions of cGAS-STING signalling

Cellular magnesium homeostasis

Intrinsic molecular activities of the interferon-induced 2-5A-dependent RNase

Suppressing PARylation by 29,59-oligoadenylate synthetase 1 inhibits DNA damage-induced cell death

The 2959 oligoadenylate synthetase has a multifunctional 2959 nucleotidyl-transferase activity

Gene structure and function of the 29-59-oligoadenylate synthetase family

Synthesis, characterisation and biological significance of (29-59)oligoadenylate derivatives of NAD1, ADP-ribose and adenosine(59)tetraphospho(59)adenosine

Ribonuclease L and metal-ion-independent endoribonuclease cleavage sites in host and viral RNAs

Identification of a novel member of 2H phosphoesterases, 29,59-oligoadenylate degrading ribonuclease from the oyster Crassostrea gigas

Small self-RNA generated by RNase L amplifies antiviral innate immunity

TLR8 is a sensor of RNase T2 degradation products

Ten strategies of interferon evasion by viruses

The role of phosphodiesterase 12 (PDE12) as a negative regulator of the innate immune response and the discovery of antiviral inhibitors

Human ADAR1 prevents endogenous RNA from triggering translational shutdown

p53 cooperates with DNA methylation and a suicidal interferon response to maintain epigenetic silencing of repeats and noncoding RNAs

A new approach to 'megaprimer' polymerase chain reaction mutagenesis without an intermediate gel purification step

Crystal structure of human nocturnin catalytic domain

Crystal structure of the 29-specific and double-stranded RNA-activated interferon-induced antiviral protein 29-59-oligoadenylate synthetase

Monitoring activation of ribonuclease L by 29,59-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells

MAFFT multiple sequence alignment software version 7: improvements in performance and usability

Human 29-phosphodiesterase localizes to the mitochondrial matrix with a putative function in mitochondrial RNA turnover

We We acknowledge support by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under awards R01AI104887 to S.R.W. and R.H.S., AI140442 to S.R.W., and R01AI135922 to R.H.S.R.H.S. is a consultant to Inception Therapeutics, Inc., and S.R.W. is on the scientific advisory boards of Immunome, Inc., and Ocugen, Inc.